Virtual Reality Cognitive Intervention for Critically Ill Delirium Survivors (VR-Cog)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorIndiana University

About this trial

The purpose of this study is to measure the feasibility, acceptability of virtual reality (VR) brain games and estimate their effect on memory, attention, and mood for ICU survivors. The VR program will be used at home through a headset and hand controls.

Eligibility criteria

Qualifiers

Adults aged 50 years or older

English speaking

Admitted to the intensive care unit (ICU) with acute respiratory failure/invasive mechanical ventilation

Screening positive for delirium (using Richmond Agitation Sedation Scale and Confusion Assessment Method for the ICU)

Disqualifiers

Acute neurologic injury such as stroke, traumatic brain injury, brain mass, intracranial hemorrhage, seizures, or central nervous system infection

Chronic cognitive or physical function deficit preventing participation in study interventions or assessments (determined by chart diagnoses and direct participant interview)

Chronic cognitive impairment (including mild cognitive impairment or dementia) identified by chart diagnosis, prescription of anti-dementia medications, or Informant Questionnaire on Cognitive Decline in the Elderly Score (IQCODE) >3.3 obtained from family caregiver

Severe, uncorrected vision or hearing impairment preventing participation in intervention or outcomes assessments

Trial design

Treatments tested in this trial

  • VR-based cognitive training program
  • VR-based attention control

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Indiana University

Lead sponsor

Indiana University Health

Collaborator